
Triphage PG 2mg/500mg/15mg Tablet ER
Marketer
Signature Phytochemical Industries
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Triphage PG 2mg/500mg/15mg Tablet ER
Combiflex DM, a 2mg/500mg/15mg extended-release tablet, is a multi-component medication designed to manage blood glucose. In adults with type 2 diabetes, it complements diet and exercise to optimize glycemic control. This medication enhances insulin effectiveness, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combiflex DM. Ingestion with food is recommended to prevent gastrointestinal discomfort. Missed doses should be taken promptly; however, if nearing the next scheduled dose, omit the missed dose and resume the regular schedule. Never double the dose. An overdose can trigger hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood sugar monitoring is crucial during treatment. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should consult their physician before using this medication. Kidney function tests will be assessed before treatment initiation. Limit alcohol consumption to minimize potential side effects.
Uses of Triphage PG 2mg/500mg/15mg Tablet ER
Managing type 2 diabetes
Major Benefits of Triphage PG 2mg/500mg/15mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Triphage PG 2mg/500mg/15mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Triphage PG 2mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Triphage PG 2mg/500mg/15mg Tablet ER:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Triphage PG 2mg/500mg/15mg Extended-Release tablet whole; do not fracture, pulverize, or chew it. Administer with food.
How Triphage PG 2mg/500mg/15mg Tablet ER works:
Triphage PG ER tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Triphage PG 2mg/500mg/15mg Extended-Release Tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Triphage PG tablets (2mg/500mg/15mg) may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Triphage PG tablets (2mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Triphage PG 2mg/500mg/15mg Extended-Release Tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Triphage PG 2mg/500mg/15mg Extended-Release Tablets are contraindicated in patients with severe kidney disease. Close monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Triphage PG 2mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Triphage PG 2mg/500mg/15mg Extended-Release tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Triphage PG 2mg/500mg/15mg Tablet ER :
Should you forget a dose of Triphage PG 2mg/500mg/15mg Extended-Release Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triphage PG 2mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Treatment |
